Description
Paxobrook – Oral Antiviral for COVID‑19 Treatment
Paxobrook is a prescription oral antiviral therapy that combines nirmatrelvir (150 mg) and ritonavir (100 mg), designed to treat mild-to-moderate COVID‑19 in adults and adolescents (≥12 years, ≥40 kg) at high risk for progression. Taken within five days of symptom onset, Paxobrook has been clinically shown to reduce the risk of hospitalization and death.
Why Choose Paxobrook?
- Potent suppression of SARS-CoV-2 via Mpro protease inhibition
- Ritonavir boosts nirmatrelvir’s effect by slowing its metabolism
- Convenient 5‑day oral treatment—no injections required
- Rapid symptom relief and viral clearance in clinical studies
How Paxobrook Works
Nirmatrelvir inhibits the SARS-CoV-2 main protease required for viral replication, while ritonavir enhances its effectiveness by inhibiting metabolic breakdown (CYP3A4). Together, they deliver extended antiviral action within the body.
Usage & Dosage
- Take two 150 mg nirmatrelvir capsules + one 100 mg ritonavir capsule twice daily
- Total course: 5 days, 30 capsules
- Can be taken with or without food; swallow all capsules whole
- Start within 5 days of symptom onset or positive test
Who Should Use It?
- Adults ≥18 and adolescents ≥12 years (≥40 kg) with confirmed mild-to-moderate COVID‑19
- Individuals at high risk of severe disease—advanced age, obesity, diabetes, heart disease, or immunocompromised status
Side Effects & Safety
Common side effects:
- Altered taste (dysgeusia)
- Diarrhea, nausea, vomiting
- Headache, muscle pain, elevated blood pressure
Severe reactions—like liver issues or allergic response—are rare. Report any serious concerns to your healthcare provider.
Precautions & Drug Interactions
- Not for use with medications heavily dependent on CYP3A (e.g., some statins, antiarrhythmics, sedatives)
- Review all prescription and OTC medications with your provider
- Caution: severe renal or hepatic impairment may require a lower dose
- Not for use in pregnant or breastfeeding women without doctor approval
Rebound Effects
Some patients may experience mild “rebound” symptoms 2–8 days after completing therapy. These are usually short-lived and not generally severe.
Storage Instructions
- Store at 20–25 °C (68–77 °F); allowed excursions 15–30 °C
- Keep in original packaging, away from moisture and light
- Keep out of reach of children and pets
Buy Paxobrook Online at ReliableVita
Get prescription-strength **Paxobrook tablets** at **ReliableVita.com**—sourced with integrity and shipped discreetly. A valid prescription is required. Consult a qualified practitioner to determine the correct therapy for your condition.
Related Products You May Also Like
- Paxlovid – Original Brand Antiviral Kit
- Nirmatrelvir 150 mg & Ritonavir 100 mg – Generic Kit
- Molaz Molnupiravir 200 mg – Alternative COVID Antiviral
Frequently Asked Questions
When should I start Paxobrook?
Initiate treatment within 5 days of symptom onset or a positive SARS‑CoV‑2 test for optimal benefit.
How many pills do I take per dose?
Each dose consists of two nirmatrelvir 150 mg capsules plus one ritonavir 100 mg capsule, taken twice daily.
Can I take it with food?
Yes, Paxobrook can be taken whether or not you’ve eaten; consistency is most important.
What are common side effects?
Expect mild side effects like altered taste, diarrhea, headache or muscle aches.
Are there any drug interactions?
Yes—Paxobrook interacts with many medications metabolized by CYP3A. Share your full medication list with your doctor.
